{"disease":{"id":"systemic-sclerosis-associated-interstitial-lung-disease-ssc-ild","name":"systemic sclerosis associated interstitial lung disease ssc ild"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03856853","title":"Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Beijing Continent Pharmaceutical Co, Ltd.","has_results":false},{"nct_id":"NCT06189495","title":"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}